Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Status:
Withdrawn
Trial end date:
2030-07-01
Target enrollment:
Participant gender:
Summary
Multi-center, prospective, randomized controlled clinical trial that will compare two
treatment methods (PGA with TOOKAD® VTP and Active Surveillance) for treating localized
prostate cancer. The study will include criteria for evaluation, biopsy, eligibility,
informed consent, subsequent management and decision making conducted based on data provided
locally at each center that follow a set of standardized criteria.